At the heart of the Mater Private Hospital group’s lawsuit against the HSE is the question of whether its shareholders, French fund Infravia Capital Partners, were allowed make money on a deal to provide spillover Covid-19 care to the public health system in the early days of the pandemic. The HSE maintains the agreement for private bed capacity was a strictly not for profit arrangement hastily forged during a national emergency in the spring of 2020. The Mater, down €6.6 million if it loses its Commercial Court case, says it is entitled to recoup its operational costs, including interest payments…

Want to continue reading?

Introductory offer: Sign up today and pay €200 for an annual membership, a saving of €100.

Subscribe

Cancel anytime.

Are you already a member? .